Metimedi Pharmaceuticals Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 27, 2026The maintenance fee for Methods of treating chronic inflammatory diseases (US 11,684,635) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 1 fee due Jul 7, 2027The maintenance fee for Pharmaceutical composition for treating cancer, containing lactate metal salt (US 10,525,022) comes due Jul 7, 2027. Unpaid by Jan 7, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,525,022 | Pharmaceutical composition for treating cancer, containing lactate metal salt In force · USPTO record | In force | USPTO record | |
| US 11,413,261 | Pharmaceutical composition for treating cancer comprising lactate metal salt In force · USPTO record | In force | USPTO record | |
| US 11,285,121 | Calcium Lactate Compositions and Methods of Use In force · High confidence | In force | High confidence | |
| US 12,059,397 | Calcium Lactate Compositions and Methods of Use In force · Medium confidence | In force | Medium confidence | |
| US 10,751,365 | Methods of treating chronic inflammatory diseases In force · USPTO record | In force | USPTO record | |
| US 10,898,514 | Methods of treating chronic inflammatory diseases In force · USPTO record | In force | USPTO record | |
| US 12,138,281 | Methods of treating chronic inflammatory diseases In force · USPTO record | In force | USPTO record | |
| US 12,576,107 | Methods of Treating Chronic Inflammatory Diseases In force · Low confidence | In force | Low confidence | |
| US 11,684,635 | Methods of treating chronic inflammatory diseases In force · USPTO record | In force | USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending